Noile-Immune Biotech
Latest round
- Series C
Last raised
- Mar 2021
Total raised
- $22M
Investors
- 7
About Noile-Immune Biotech
Noile-Immune Biotech Inc.Founded in 2015 and headquartered in Tokyo, Japan, Noile-Immune Biotech Inc. specializes in the development of advanced cancer immunotherapies.Noile-Immune Biotech Inc. specializes in developing innovative cancer immunotherapies, particularly CAR-T cell therapy, which utilizes the immune system to effectively target and eliminate cancer cells. Their leading product is based on NOILE technology, enhancing CAR-T therapies' versatility and scalability.In the most recent fiscal year, 2020, Noile-Immune Biotech Inc. The company is targeting expansion into new markets, with plans to enhance its presence in North America and Europe by the end of 2023, while also advancing its product offerings in the oncology sector.
Who invested in Noile-Immune Biotech
7 investors across 1 round
See all investors in Noile-Immune Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Mar 22, 2021
Amount
$22M
Investors
Questions about Noile-Immune Biotech
Who invested in Noile-Immune Biotech?
Noile-Immune Biotech has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Noile-Immune Biotech raised?
Noile-Immune Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Noile-Immune Biotech last raise money?
Noile-Immune Biotech's most recent round on record is a Series C, in Mar 2021.
What does Noile-Immune Biotech do?
Noile-Immune Biotech is a biotechnology company.
Where is Noile-Immune Biotech headquartered?
Noile-Immune Biotech is headquartered in Tokyo, Japan.
Which VCs invest in companies like Noile-Immune Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Noile-Immune Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Noile-Immune Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.